An Open-label, Long-term, Safety and Efficacy Study of Aticaprant as Adjunctive Therapy in Adult and Elderly Participants With Major Depressive Disorder (MDD)
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
DepressionDrug
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What the source confirms
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
What should you check before joining?
Check the official protocol for eligibility, treatment, visits and assessments. If recruitment is listed, confirm with the team that a specific centre is still accepting participants before taking any next step.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateNot clearly listed
Recruitment status
Not recruiting
Enrollment listed in the registry
840
Sponsor
Janssen-Cilag International NV
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
France, Belgium, Bulgaria, ...
Age range
Not clearly listed
Official registry ID
EUCTR 2022-000430-42
Official title
An Open-label, Long-term, Safety and Efficacy Study of Aticaprant as Adjunctive Therapy in Adult and Elderly Participants With Major Depressive Disorder (MDD)
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: EUCTR 2022-000430-42. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
EU CTR and CTIS records checked by HopeStage on . Registry information can change. Always confirm availability with the research team.
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
CCAB Centro Clinico Academico Braga Associacao — Psychiatry
Braga
Country status: Not recruiting
Champalimaud Clinical Centre — Neuropsychiatry
Lisbon
Country status: Not recruiting
Hospital Cuf Tejo S.A. — Psychiatry
Lisbon
Country status: Not recruiting
Slovakia · 8 sites
Dana Ignjatovičová, spol. s.r.o., — Dana Ignjatocivoa, spol. s.r.o.
Banská Bystrica
Country status: Not recruiting
Nemocnica S Poliklinikou Prievidza So Sidlom V Bojniciach — Psychiatric
Bojnice
Country status: Not recruiting
Univerzitna nemocnica L. Pasteura Kosice — II. Psychiatric clinic
Kosice
Country status: Not recruiting
Epamed s.r.o. — EPAMED s.r.o.
Kosice - Zapad
Country status: Not recruiting
Liptovska Nemocnica S Poliklinikou Mudr. Ivana Stodolu Liptovsky Mikulas — Psychiatric
Liptovsky Mikulas
Country status: Not recruiting
PsychoLine s.r.o. — PsychoLine s.r.o.
Rimavska Sobota
Country status: Not recruiting
Mentum s.r.o. — MENTUM, s.r.o.
Stare Mesto
Country status: Not recruiting
Crystal Comfort s.r.o. — Crystal Comfort s.r.o.
Vranov Nad Toplou
Country status: Not recruiting
Spain · 8 sites
Hestia Palau S.L. — Psychiatry
Barcelona
Country status: Not recruiting
Hospital Clinic De Barcelona — Psychiatry
Barcelona
Country status: Not recruiting
Hospital Universitari Vall D Hebron — Psychiatry
Barcelona
Country status: Not recruiting
Hospital Universitario La Paz — Psychiatry
Madrid
Country status: Not recruiting
Hospital El Bierzo — Psychiatry
Ponferrada
Country status: Not recruiting
Parc Tauli Hospital Universitari — Psychiatry
Sabadell
Country status: Not recruiting
Hospital Alvaro Cunqueiro — Psychiatry
Vigo
Country status: Not recruiting
Red de Salud Mental de Araba (Hospital Psiquiátrico de Araba) — Psychiatry
Vitoria-Gasteiz
Country status: Not recruiting
Sweden · 4 sites
Sahlgrenska University Hospital-Vaestra Goetalandsregionen — Hematology
Goteborg
Country status: Not recruiting
ProbarE i Lund AB — Hematology
Lund
Country status: Not recruiting
ProbarE i Stockholm AB — Hematology
Stockholm
Country status: Not recruiting
Region Stockholm – SLSO — Hematology
Stockholm
Country status: Not recruiting
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What does the official source confirm?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Is this study recruiting?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
How can I check the participation requirements?
Check the official protocol for the criteria, treatment and planned assessments. The research team must confirm visits, risks, open centres and your eligibility.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
